A. Akimov and V. Cherniavskyi, “Comparative effects of liraglutide and dapagliflozin on lipid profile and cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: a 6-month randomized study”, USMYJ, vol. 158, no. 4, pp. 17-26, Dec. 2025.